L. Long

发表

Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression

J. Byrd, M. Minden, J. Blachly, 2020, Clinical Cancer Research.

Persistent psychological distress in long‐term survivors of pediatric sarcoma: the experience at a single institution

C. Mackall, L. Wiener, H. Battles, 2006, Psycho-oncology.

A Pilot Study of Consolidative Immunotherapy in Patients with High-Risk Pediatric Sarcomas

J. Berzofsky, L. Helman, C. Mackall, 2008, Clinical Cancer Research.

Treatment of Metastatic Osteosarcoma With the Somatostatin Analog OncoLar: Significant Reduction of Insulin-Like Growth Factor-1 Serum Levels

S. Steinberg, G. Chrousos, D. Hawkins, 2002, Journal of pediatric hematology/oncology.

Randomized Trial and Pharmacokinetic Study of Pegfilgrastim versus Filgrastim after Dose-Intensive Chemotherapy in Young Adults and Children with Sarcomas

S. Steinberg, D. Hawkins, L. Helman, 2009, Clinical Cancer Research.

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.

J. Berzofsky, L. Helman, C. Mackall, 2002, Medical and pediatric oncology.

Sicca Syndrome Associated with Immune Checkpoint Inhibitor Therapy.

E. Lipson, D. Kleiner, J. Feliciano, 2019, The oncologist.

SARC 006 : Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

Robin L. Jones, S. Steinberg, D. Reinke, 2017 .

SARC006: Phase II Trial of Chemotherapy in Sporadic and Neurofibromatosis Type 1 Associated Chemotherapy-Naive Malignant Peripheral Nerve Sheath Tumors

Robin L. Jones, S. Steinberg, D. Reinke, 2017, Sarcoma.

Thromboembolic events in children and young adults with pediatric sarcoma.

L. Helman, C. Mackall, A. Wayne, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular Confirmation of Ewing Sarcoma

M. Raffeld, L. Helman, C. Mackall, 2001, Journal of pediatric hematology/oncology.

Adjuvant chemotherapy for the treatment of advanced pediatric nonrhabdomyosarcoma soft tissue sarcoma: The national cancer institute experience

P. Nathan, L. Helman, C. Mackall, 2005, Pediatric blood & cancer.

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

J. Berzofsky, D. Douek, B. Hill, 2005, Nature Medicine.

Interferon- (cid:1) Sensitizes Resistant Ewing’s Sarcoma Cells to Tumor Necrosis Factor Apoptosis-Inducing Ligand-Induced Apoptosis by Up-Regulation of Caspase-8 Without Altering Chemosensitivity

Lauren Long, C. Niemeyer, U. Kontny, 2007 .

SARC006: Phase II trial of chemotherapy in sporadic and neurofibromatosis type 1 (NF1)-associated high-grade malignant peripheral nerve sheath tumors (MPNSTs).

S. Steinberg, D. Reinke, S. Schuetze, 2013 .

Treatment late effects in long‐term survivors of pediatric sarcoma

P. Nathan, S. Steinberg, L. Gerber, 2007, Pediatric blood & cancer.

A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS–FLI1 fusion transcript

L. Helman, B. Widemann, W. Figg, 2017, Cancer Chemotherapy and Pharmacology.